HK1133185A1 - Optimized fluorocarbon emulsions for blood substitutes and other therapeutic uses - Google Patents

Optimized fluorocarbon emulsions for blood substitutes and other therapeutic uses

Info

Publication number
HK1133185A1
HK1133185A1 HK09111280.7A HK09111280A HK1133185A1 HK 1133185 A1 HK1133185 A1 HK 1133185A1 HK 09111280 A HK09111280 A HK 09111280A HK 1133185 A1 HK1133185 A1 HK 1133185A1
Authority
HK
Hong Kong
Prior art keywords
emulsions
bromide
optimized
therapeutic uses
perfluorodecyl
Prior art date
Application number
HK09111280.7A
Other languages
English (en)
Inventor
Jeffrey Weers
David Klein
Cindy Johnson
Original Assignee
Alliance Phamaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alliance Phamaceutical Corp filed Critical Alliance Phamaceutical Corp
Publication of HK1133185A1 publication Critical patent/HK1133185A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK09111280.7A 2006-05-22 2009-12-02 Optimized fluorocarbon emulsions for blood substitutes and other therapeutic uses HK1133185A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80233906P 2006-05-22 2006-05-22
PCT/US2007/012286 WO2007139827A2 (fr) 2006-05-22 2007-05-22 Émulsions optimisées de fluorocarbone pour substituts sanguins et autres usages thérapeutiques

Publications (1)

Publication Number Publication Date
HK1133185A1 true HK1133185A1 (en) 2010-03-19

Family

ID=38779190

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09111280.7A HK1133185A1 (en) 2006-05-22 2009-12-02 Optimized fluorocarbon emulsions for blood substitutes and other therapeutic uses

Country Status (9)

Country Link
US (1) US8748497B2 (fr)
EP (1) EP2034959B1 (fr)
JP (1) JP5205369B2 (fr)
KR (1) KR20090023620A (fr)
CN (1) CN101448485B (fr)
AU (1) AU2007267997A1 (fr)
CA (1) CA2655140A1 (fr)
HK (1) HK1133185A1 (fr)
WO (1) WO2007139827A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5757549B2 (ja) * 2009-10-16 2015-07-29 栄研化学株式会社 卵黄液による発色反応および／または蛍光発色反応増強作用
WO2012003457A1 (fr) * 2010-07-01 2012-01-05 Mtm Research Llc Thérapies au moyen d'émulsions fluorochimiques antifibroblastiques
CN103505416B (zh) * 2013-09-24 2016-06-15 上海纳米技术及应用国家工程研究中心有限公司 一种携氧氟碳乳剂及其制备方法
CN103505419B (zh) * 2013-09-24 2016-01-13 上海纳米技术及应用国家工程研究中心有限公司 一种低表面张力的载氧脂质体及其制备方法
JP2015126756A (ja) * 2015-04-10 2015-07-09 栄研化学株式会社 卵黄液による発色反応および／または蛍光発色反応増強作用
CN105248412A (zh) * 2015-10-30 2016-01-20 暨南大学 一种乳化氟碳液在制备肺器官保存液中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3958014A (en) * 1970-09-05 1976-05-18 The Green Cross Corporation Process for preparing injection-purpose fluorocarbon emulsion capable of carrying oxygen
US5080885A (en) 1986-01-14 1992-01-14 Alliance Pharmaceutical Corp. Brominated perfluorocarbon emulsions for internal animal use for contrast enhancement and oxygen transport
US4927623A (en) * 1986-01-14 1990-05-22 Alliance Pharmaceutical Corp. Dissolution of gas in a fluorocarbon liquid
US5628930A (en) 1992-10-27 1997-05-13 Alliance Pharmaceutical Corp. Stabilization of fluorocarbon emulsions
US5595687A (en) * 1992-10-30 1997-01-21 Thomas Jefferson University Emulsion stability
US5635538A (en) * 1993-03-16 1997-06-03 Alliance Pharmaceutical Corp. Fluorocarbon emulsions with reduced pulmonary gas-trapping properties
US5865784A (en) * 1995-06-07 1999-02-02 Alliance Pharmaceutical Corp. Method of hemodilution facilitated by monitoring oxygenation status

Also Published As

Publication number Publication date
WO2007139827A3 (fr) 2008-01-31
WO2007139827A8 (fr) 2009-02-12
US8748497B2 (en) 2014-06-10
EP2034959A2 (fr) 2009-03-18
JP5205369B2 (ja) 2013-06-05
JP2009538311A (ja) 2009-11-05
CN101448485B (zh) 2013-01-09
CA2655140A1 (fr) 2007-12-06
EP2034959A4 (fr) 2012-03-28
AU2007267997A1 (en) 2007-12-06
US20100298445A1 (en) 2010-11-25
WO2007139827A2 (fr) 2007-12-06
CN101448485A (zh) 2009-06-03
EP2034959B1 (fr) 2017-01-11
KR20090023620A (ko) 2009-03-05
AU2007267997A8 (en) 2009-09-24

Similar Documents

Publication Publication Date Title
HK1133185A1 (en) Optimized fluorocarbon emulsions for blood substitutes and other therapeutic uses
CL2009001252A1 (es) Preparacion alimenticia que produce una sensacion de cosquilleo o quemante que comprende acido acilamino o una sal de el usos.
EA201490804A1 (ru) Препараты этанерцепта, стабилизированные хлоридом натрия
MXPA05012023A (es) Composiciones para tratamiento de la piel humeda que comprenden estructuras reticulares de gel.
WO2007089473A8 (fr) Composition de fluide épaissie comprenant du dioxyde de chlore
EA201070121A1 (ru) Лекарственная форма, содержащая слитый белок glp-1-fc
BR112015029254A2 (pt) composição detergente de baixo ph compreendendo tensoativos não iônicos
BR112015018847A2 (pt) produtos alimentícios reduzidos em sódio
WO2009035540A3 (fr) Analogues d'exendine-4 et exendine-3
WO2008111358A1 (fr) Composition pour la stabilisation de dioxyde de chlore
BR112014011670A2 (pt) anticorpo anti- adrenomedulina (adm) ou fragmento de anticorpo anti -adm ou uma estrutura anti- adm não-ig para utilização em terapia
WO2012007301A3 (fr) Amélioration de la mousse des tensioactifs du type glycinate d'acyle gras
CL2007003873A1 (es) Metodo para producir cloramina estable que comprende combinar fuente de cloro concentrado con fuente de amina concentrada y agitar para producir cloramina estable con ph>5.
GB2533518A (en) Volatile surfactant treatment for subterranean formations
ATE445692T1 (de) Polydextrose induzierte zweiphasige zusammensetzung
TNSN07263A1 (en) Substituted 4-phenyl tetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them
EA201690079A1 (ru) Композиция, содержащая глутаминовую-n,n-диуксусную кислоту (glda), воду и фермент
WO2010022873A3 (fr) Structures liposomales formant des agglomérats isométriques, notamment des perles de bain, leur production et leur utilisation
BR112014010828A2 (pt) estabilização de emulsão
JP2007308378A5 (fr)
SG159481A1 (en) Stabilization of thermolysin in aqueous solution
IN2014MN00929A (fr)
EA200900740A1 (ru) Замещенные хиназолины
GB2456965A (en) Skin cleansing compositions
MA32480B1 (fr) Compositions pédiatriques pour le traitement de la sclérose en plaques

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170522